<DOC>
	<DOCNO>NCT01628588</DOCNO>
	<brief_summary>This observational study Lumigan® 0.01 % ( bimatoprost ) treatment clinical practice patient Primary Open Angle Glaucoma ( POAG ) Ocular Hypertension ( OHT ) .</brief_summary>
	<brief_title>Lumigan® Patients With Primary Open Angle Glaucoma ( POAG ) Ocular Hypertension ( OHT )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<criteria>Diagnosis primary open angle glaucoma ocular hypertension Prescribed Lumigan®</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>